NEWM&A
Jardine Matheson (J36) Acquires I-MED for $2.4 Billion
Published on 5/25/2026

AI Summary
Jardine Matheson (J36) announced a plan to acquire I-MED for an enterprise value of $2.4 billion. This transaction signifies Jardine's strategic move into the healthcare sector, aiming to enhance its portfolio. The acquisition highlights the ongoing trend of consolidation in healthcare, which could affect market dynamics and investor sentiment. The deal's size indicates a significant investment and could lead to further opportunities in healthcare ventures.
Related News

M&A
Jardine Matheson (JMHLY) Acquires I-MED for $2.4 Billion
May 25

M&A
Sun Pharmaceuticals (SUN) Acquires Organon & Co for $11.75 Billion
May 24

M&A
Uber (UBER) Considering Higher Bid for Delivery Hero After €11.5Bn Rejection
May 24

M&A
Compass Inc. (COMP) SWOT Analysis Shows Growth Potential Post-Acquisition
May 24